CAS 1357362-02-7

ORY-2001

Description:

ORY-2001, identified by its CAS number 1357362-02-7, is a chemical compound that has garnered attention in pharmaceutical research, particularly for its potential therapeutic applications. It is characterized as a small molecule with a specific structure that allows it to interact with biological targets, potentially influencing various biochemical pathways. The compound is often studied for its efficacy and safety in treating certain medical conditions, and its mechanism of action may involve modulation of specific receptors or enzymes within the body. As with many investigational drugs, ORY-2001 undergoes rigorous testing in preclinical and clinical trials to assess its pharmacokinetics, pharmacodynamics, and overall therapeutic profile. Its solubility, stability, and bioavailability are critical factors that researchers evaluate to determine its suitability for development. While detailed information on its characteristics may vary, ongoing studies aim to elucidate its full potential and any associated side effects, contributing to the broader understanding of its role in medicinal chemistry.

Formula: C₁₉H₂₀N₄O₂

Synonyms:

• ORY-2001
• Vafidemstat (ORY-2001)

Vafidemstat

CAS: 1357362-02-7

Vafidemstat

Purity: ≥98%

Molecular weight: 336.39g/mol

Ref: 54-BUP21602

Vafidemstat

CAS: 1357362-02-7

Vafidemstat is a tetracycline compound that has been shown to be effective in the treatment of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. It is able to penetrate the blood-brain barrier and act on the central nervous system. Vafidemstat inhibits hyperactivity by increasing the concentration of gamma-aminobutyric acid (GABA) in the brain, which may be due to its ability to inhibit chloride transport into cells. Vafidemstat also increases GABA concentrations in lymphatic vessels, which may contribute to its anti-inflammatory effects.

Formula: C₁₉H₂₀N₄O₂

Purity: Min. 95%

Molecular weight: 336.4 g/mol

Ref: 3D-HEC36202

Vafidemstat

CAS: 1357362-02-7

Vafidemstat (ORY-2001) is a lysine-histone demethylase (LSD1)/MAO-B inhibitor for the study of neurological disorders.

Formula: C₁₉H₂₀N₄O₂

Purity: 99.53%

Color and Shape: Solid

Molecular weight: 336.39

Ref: TM-T17211